Literature DB >> 35382120

Development and preliminary validation of the Scleroderma Support Group Leader Self-efficacy Scale.

Nicole E Pal1, Stephanie T Gumuchian1,2, Vanessa C Delisle1,2, Mia Pépin1, Vanessa L Malcarne3,4, Marie-Eve Carrier1, Linda Kwakkenbos1,5,6, Sandra Peláez1,2, Ghassan El-Baalbaki7, Brett D Thombs1,2,4,8,9.   

Abstract

Support groups are an important resource for people living with systemic sclerosis (SSc; scleroderma). Peer support group leaders play an important role in the success and sustainability of SSc support groups, but face challenges that include a lack of formal training. An SSc support group leader training program could improve leader self-efficacy to carry out important leadership tasks, including the management of group dynamics. However, no measures exist to assess self-efficacy among SSc support group leaders. The objective of this study was to develop and provide preliminary evidence on the reliability and validity of the Scleroderma Support Group Leader Self-efficacy Scale (SSGLSS). The SSGLSS was administered to two sets of SSc support group leaders from North America, Europe, and Australia. Study 1 participants (n = 102) completed the SSGLSS only. Study 2 participants (n = 55) completed the SSGLSS and the Oldenburg Burnout Inventory (OLBI). For both studies, we evaluated internal consistency reliability using Cronbach's coefficient alpha. Convergent validity was assessed in Study 2 using Pearson correlations of the SSGLSS with the OLBI exhaustion and disengagement subscales. Cronbach's alpha was 0.96 in Study 1 and 0.95 in Study 2. Consistent with our hypotheses, there was a small negative correlation between SSGLSS scores and the OLBI exhaustion subscale (r = -0.25, p<0.01) and a moderate negative correlation between SSGLSS scores and the disengagement subscale (r = -0.38, p<0.01). These results suggest that the SSGLSS is a reliable and valid measure of self-efficacy for carrying out support group leadership tasks.
© The Author(s) 2017.

Entities:  

Keywords:  Patient-reported outcome measures; Psychometrics; Scleroderma; Self-help groups; Social support; Systemic

Year:  2017        PMID: 35382120      PMCID: PMC8892874          DOI: 10.5301/jsrd.5000260

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  10 in total

1.  Sustaining leaders of cancer support groups: the role, needs, and difficulties of leaders.

Authors:  Phyllis Butow; Jane Ussher; Laura Kirsten; Kim Hobbs; Katharine Smith; Gerald Wain; Mirjana Sandoval; Annie Stenlake
Journal:  Soc Work Health Care       Date:  2005

2.  Reasons for Not Participating in Scleroderma Patient Support Groups: A Cross-Sectional Study.

Authors:  Stephanie T Gumuchian; Vanessa C Delisle; Sandra Peláez; Vanessa L Malcarne; Ghassan El-Baalbaki; Linda Kwakkenbos; Lisa R Jewett; Marie-Eve Carrier; Mia Pépin; Brett D Thombs
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-01-11       Impact factor: 4.794

3.  Empowerment of patients: lessons from the rare diseases community.

Authors:  Ségolène Aymé; Anna Kole; Stephen Groft
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

4.  Associations between job burnout and self-efficacy: a meta-analysis.

Authors:  Kotaro Shoji; Roman Cieslak; Ewelina Smoktunowicz; Anna Rogala; Charles C Benight; Aleksandra Luszczynska
Journal:  Anxiety Stress Coping       Date:  2015-07-14

Review 5.  Perceived Benefits and Factors that Influence the Ability to Establish and Maintain Patient Support Groups in Rare Diseases: A Scoping Review.

Authors:  Vanessa C Delisle; Stephanie T Gumuchian; Danielle B Rice; Alexander W Levis; Lorie A Kloda; Annett Körner; Brett D Thombs
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

Review 6.  Cancer support groups: meeting the needs of African Americans with cancer.

Authors:  F K Barg; M M Gullatte
Journal:  Semin Oncol Nurs       Date:  2001-08       Impact factor: 2.315

7.  Who talks? The social psychology of illness support groups.

Authors:  K P Davison; J W Pennebaker; S S Dickerson
Journal:  Am Psychol       Date:  2000-02

8.  Exploring the impact of training on the experience of Australian support group leaders: current practices and implications for research.

Authors:  Rachel D Zordan; Ilona Juraskova; Phyllis N Butow; Afsaneh Jolan; Laura Kirsten; Julie Chapman; Christine Sedgwick; Margaret Charles; Kendra Sundquist
Journal:  Health Expect       Date:  2010-12       Impact factor: 3.377

9.  Reasons for non-participation in scleroderma support groups.

Authors:  Vanessa C Delisle; Stephanie T Gumuchian; Sandra Pelaez; Vanessa L Malcarne; Ghassan El-Baalbaki; Annett Körner; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Clin Exp Rheumatol       Date:  2016-02-25       Impact factor: 4.473

10.  The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.

Authors:  Linda Kwakkenbos; Lisa R Jewett; Murray Baron; Susan J Bartlett; Dan Furst; Karen Gottesman; Dinesh Khanna; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Serge Poiraudeau; Maureen Sauve; Warren R Nielson; Janet L Poole; Shervin Assassi; Isabelle Boutron; Carolyn Ells; Cornelia Hm van den Ende; Marie Hudson; Ann Impens; Annett Körner; Catarina Leite; Angela Costa Maia; Cindy Mendelson; Janet Pope; Russell J Steele; Maria E Suarez-Almazor; Sara Ahmed; Stephanie Coronado-Montoya; Vanessa C Delisle; Shadi Gholizadeh; Yeona Jang; Brooke Levis; Katherine Milette; Sarah D Mills; Ilya Razykov; Rina S Fox; Brett D Thombs
Journal:  BMJ Open       Date:  2013-08-07       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.